Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
CareDx, Inc. - Common Stock
(NQ:
CDNA
)
13.82
+0.72 (+5.50%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CareDx, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
February 13, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Raymond James Maintains Strong Buy Rating for CareDx: Here's What You Need To Know
January 31, 2023
Via
Benzinga
Where CareDx Stands With Analysts
January 31, 2023
Via
Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
January 27, 2023
The growth-focused money manager is making moves.
Via
The Motley Fool
JACC Publication Guides Use of CareDx’s HeartCare Transplant Rejection Surveillance in Clinical Practice
January 26, 2023
From
CareDx, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
October 20, 2022
Thursday saw 177 companies set new 52-week lows.
Via
Benzinga
Don’t Put CareDX Stock in Your Portfolio’s Pipeline
October 20, 2022
Unfortunately, CDNA stock is a losing investment in a company with an interesting concept but poor financial execution.
Via
InvestorPlace
CareDx Fosters Transplant Innovation as Distinguished Founder’s Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter Symposium
January 11, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022
January 09, 2023
From
CareDx, Inc.
Via
Business Wire
CAREDX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CareDx, Inc. - CDNA
December 30, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
New ISHLT Guidelines Support Use of CareDx’s HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant Patients
December 21, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx Announces $50 Million Stock Repurchase Program
December 06, 2022
From
CareDx, Inc.
Via
Business Wire
CAREDX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CareDx, Inc. - CDNA
December 05, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Independent Prospective Study Defines Reference Range for CareDx’s AlloSure for Long-Term Lung Transplant Surveillance
December 01, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx Committed to Delivering Clinical Innovation to the Transplant Patient and Physician Community
November 11, 2022
From
CareDx, Inc.
Via
Business Wire
Yelp, Twilio, Atlassian, And Other Big Losers From Friday
November 07, 2022
U.S. stocks closed higher on Friday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
November 04, 2022
Gainers
Via
Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
November 07, 2022
Gainers
Via
Benzinga
CareDx To Participate in Upcoming Investor Conferences
November 04, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Third Quarter 2022 Results
November 03, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week
November 02, 2022
From
CareDx, Inc.
Via
Business Wire
Independent Longitudinal Study Finds CareDx’s AlloSure Detects Early Signs of Rejection in Pediatric Kidney Transplant Patients
November 01, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx Congratulates C-Path's Transplant Therapeutics Consortium and Paris Transplant Group for Receiving EMA Draft Qualification for iBox Scoring System
October 27, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx to Report Third Quarter 2022 Financial Results
October 26, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx Joins Forces with National Kidney Foundation and Honor the Gift Coalition to Host Immuno Bill Webinar for Kidney Transplant Patients
October 26, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx Presents Latest Data on AlloSeq NGS Solutions and Transplant Innovation at the American Society for Histocompatibility and Immunogenetics Annual Meeting
October 25, 2022
From
CareDx, Inc.
Via
Business Wire
5 Top Stocks Cathie Wood Is Buying This Week
September 30, 2022
There's a new Ark fund in town, and its name is the ARK Venture Fund. It will capitalize on democratizing private investments to the public.
Via
InvestorPlace
CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care
September 29, 2022
From
CareDx, Inc.
Via
Business Wire
Transplant Patients Experience Less Pain and Fewer Adverse Events with CareDx Non-Invasive Testing Solutions
September 27, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx Congratulates Board Member Dr. Grace Colón for Being Named Healthcare Innovator on Top 50 Most Powerful Latinas List
September 26, 2022
From
CareDx, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.